There are several ongoing research studies at the TMH right now. Below is a summary of the studies currently in progress.

On Going Trials

1) Medulloblastoma Trials:

Optimizing the physical and biological parameters in craniospinal irradiation (CSI) for embryonal CNS (central nervous system) tumors: a prospective study

2) Brain-stem glioma trials:

Concomitant and adjuvant Temozolomide with radical radiotherapy in children with brain stem gliomas – a prospective study

3) MGMT Trials:

Genome wide expression profiling to determine the molecular basis of sensitivity to Temozolomide in patients with Glioblastoma multiforme

4) 2 DG Trials:

A randomized controlled comparative trial to evaluate the efficacy and safety of 2-Deoxy –D- Glucose (2DG) as a radiomodifier in the treatment of Glioblastoma Multiforme.

5) SCRT :- Stereotactic Conformal Radiotherapy  (SCRT) Trials

Brain tumours are the commonest solid tumours in children and the second most common neoplasms overall in this patient population.

Please feel free to contact any of us should you require more information about the research trial going on in the unit. If you have any patient seemingly eligible for any of our trial, feel free to write to us or send us an email.